Korean Medical Education Review (의학교육논단)

Yonsei university college of medicine (연세대학교 의과대학)
권호 표지
DOI QR코드

DOI QR Code

Educating Healthcare Professionals in Pharmacovigilance: Global Trends and Korea's Status

보건의료인을 위한 약물감시교육의 해외 동향 및 국내 현황

  • 박소희 (성균관대학교 약학대학) ;
  • 정규혁 (성균관대학교 약학대학) ;
  • 박병주 (서울대학교 의과대학 예방의학교실) ;
  • 강동윤 (서울대학교병원 약물안전센터) ;
  • 신주영 (성균관대학교 약학대학)
  • Received : 2019.09.30
  • Accepted : 2019.12.09
  • Published : 2020.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

This narrative review introduces global trends in pharmacovigilance (PV) education for healthcare professionals and the status of PV education in Korea. Proactive participation of healthcare professionals, including physicians, pharmacists, and nurses in reporting suspected adverse events is the main driving force for effective operation of the spontaneous adverse event reporting system database, which in turn facilitates early safety signal detection of otherwise unknown suspected adverse events. The World Health Organization recognizes PV education curriculum as a key aspect in promoting awareness of PV and adverse event reporting among healthcare professionals, and multiple studies have demonstrated that PV educational interventions for healthcare professionals have increased overall adverse event reporting. Considering the global trends in PV education, the curriculum in Korean universities still has room for improvement in promoting PV obligation among future healthcare professionals. Further research is needed to develop PV education curriculum. We suggest a three-step project for innovating PV education in Korea to meet the global PV educational standards: a survey to gauge current PV competencies among healthcare professionals, reform of current PV academic curriculum, and evaluation and fine-tuning of the reformed curriculum.

Keywords

References

  1. World Health Organization. The safety of medicines in public health programmes: pharmacovigilance, an essential tool. Geneva: World Health Organization; 2006.
  2. Kim YS. Post-marketing surveillance. JPERM. 2008;1(1):8-12.
  3. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-9. https://doi.org/10.1016/S0140-6736(00)02799-9
  4. Witts LJ. Adverse reactions to drugs. Br Med J. 1965;2(5470):1081-6. https://doi.org/10.1136/bmj.2.5470.1081
  5. World Health Organization. The importance of pharmacovigilance. Geneva: World Health Organization; 2002.
  6. Shin JY, Shin E, Jeong HE, Kim JH, Lee EK. Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia-Pacific region: survey results from 15 countries. Pharmacoepidemiol Drug Saf. 2019;28(3):362-9. https://doi.org/10.1002/pds.4717
  7. Chan CL, Ang PS, Li SC. A survey on pharmacovigilance activities in ASEAN and selected non-ASEAN countries, and the use of quantitative signal detection algorithms. Drug Saf. 2017;40(6):517-30. https://doi.org/10.1007/s40264-017-0510-9
  8. Suwankesawong W, Dhippayom T, Tan-Koi WC, Kongkaew C. Pharmacovigilance activities in ASEAN countries. Pharmacoepidemiol Drug Saf. 2016;25(9):1061-9. https://doi.org/10.1002/pds.4023
  9. Shin SM, Chung S, Park BJ. An overview of MedWatch system. JPERM. 2013;6(2):73-8.
  10. Moore N. The role of the clinical pharmacologist in the management of adverse drug reactions. Drug Saf. 2001;24(1):1-7. https://doi.org/10.2165/00002018-200124010-00001
  11. Egberts TC, Smulders M, de Koning FH, Meyboom RH, Leufkens HG. Can adverse drug reactions be detected earlier?: a comparison of reports by patients and professionals. BMJ. 1996;313(7056):530-1. https://doi.org/10.1136/bmj.313.7056.530
  12. Hall M, McCormack P, Arthurs N, Feely J. The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol. 1995;40(2):173-5. https://doi.org/10.1111/j.1365-2125.1995.tb05774.x
  13. Hornbuckle K, Wu HH, Fung MC. Evaluation of spontaneous adverse event reports by primary reporter: a 15-year review (1983 to 1997). Drug Inf J. 1999;33(4):1117-24. https://doi.org/10.1177/009286159903300416
  14. Seong JM, Park BJ. Recent advance in pharmacovigilance activities of World Health Organization and U.S. Food and Drug Administration. Korean Public Health Res. 2015;41(2):19-28. https://doi.org/10.22900/KPHR.2015.41.2.002
  15. Van den Bemt PM, Egberts TC, de Jong-van den Berg LT, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321-33. https://doi.org/10.2165/00002018-200022040-00005
  16. Song HJ, Choi NK, Park BJ. Adverse drug reaction surveillance and the role of family physicians. J Korean Acad Fam Med. 2007;28(11):815-23.
  17. Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235-48. https://doi.org/10.1007/s00228-018-2500-y
  18. Shankar PR, Subish P, Mishra P, Dubey AK. Teaching pharmacovigilance to medical students and doctors. Indian J Pharmacol. 2006;38(5):316-9. https://doi.org/10.4103/0253-7613.27698
  19. Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy programmes. Pharmacoepidemiol Drug Saf. 2013;22(3):223-8. https://doi.org/10.1002/pds.3311
  20. Cox AR, Marriott JF, Wilson KA, Ferner RE. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther. 2004;29(1):31-5. https://doi.org/10.1046/j.1365-2710.2003.00533.x
  21. John LJ, Arifulla M, Cheriathu JJ, Sreedharan J. Reporting of adverse drug reactions: an exploratory study among nurses in a teaching hospital, Ajman, United Arab Emirates. Daru. 2012;20(1):44. https://doi.org/10.1186/2008-2231-20-44
  22. Rajesh R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among health care professionals in an Indian tertiary care teaching hospital. Int J Pharm Tech Res. 2011;3(2):678-92.
  23. Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743-59. https://doi.org/10.1007/s40264-014-0216-1
  24. Van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003-11. https://doi.org/10.1007/s40264-018-0681-z
  25. Ahn SH, Chung S, Jung SY, Shin JY, Park BJ. Awareness of adverse drug reaction reporting system in general population. Health Policy Manag. 2014;24(2):164-71. https://doi.org/10.4332/KJHPA.2014.24.2.164
  26. Choi NK, Kwon HB, Lee AY, Park BJ. A survey on attitudes and awareness of physicians and pharmacists regarding spontaneous reporting system and experience for adverse drug events in Goyang-si. JPERM. 2008;1(1):44-52.
  27. Kyung EJ, Rew JH, Oh M, Kim E Y. A survey on attitude and awareness of health-care professionals regarding pharmacovigilance system and experience for adverse drug reaction (ADR) from a single university hospital. Korean J Clin Pharm. 2013;23(3):256-68.
  28. Lee MS, Choi AH, Jang BH, Kim NY, Lee JM, Shin JY, et al. Investigation on perceptions, attitudes, and contributing factors to spontaneous adverse drug reaction reporting among community pharmacists: results from a web-based survey. Korean J Clin Pharm. 2019;29(2):125-32. https://doi.org/10.24304/kjcp.2019.29.2.125
  29. Yu YM, Kim S, Choi KH, Jeong KH, Lee E. Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education. Basic Clin Pharmacol Toxicol. 2019;124(5):591-9. https://doi.org/10.1111/bcpt.13170
  30. Hartman J, Harmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(7):891-9. https://doi.org/10.1007/s00228-017-2237-z
  31. Seoul National University Course Registration System. Syllabus of clinical pharmacology and clerkship [Internet]. Seoul: Seoul National University; 2019 [cited 2019 Nov 20]. Available from: http://sugang.snu.ac.kr/sugang/cc/cc103.action?openSchyy=2019&openShtmFg=U000200001&openDetaShtmFg=U000300001&sbjtCd=801.469
  32. Seoul National University. Graduate curriculum, college of medicine [Internet]. Seoul: Seoul National University; 2018 [cited 2019 Nov 19]. Available from: http://en.snu.ac.kr/curriculum.
  33. Durrieu G, Hurault C, Damase-Michel C, Montastruc JL. Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students. Fundam Clin Pharmacol. 2010;24(4):423-7.
  34. Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rolfes L, van Puijenbroek EP, et al. Feasibility and educational value of a student-run pharmacovigilance programme: a prospective cohort study. Drug Saf. 2017;40(5):409-18. https://doi.org/10.1007/s40264-016-0502-1
  35. Van Eekeren R, Schutte T. Netherlands national education programme. Uppsala Rep. 2015;70:18.
  36. Christensen ST, Sondergaard B, Honore PH, Bjerrum OJ. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting. Pharmacoepidemiol Drug Saf. 2011;20(4):399-404. https://doi.org/10.1002/pds.2069
  37. Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48(Suppl 1):S69-73.
  38. Baniasadi S, Habibi M, Haghgoo R, Karimi Gamishan M, Dabaghzadeh F, Farasatinasab M, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014;13(1):291-7.
  39. Sears EL, Generali JA. Adverse drug reaction and medication error reporting by pharmacy students. Ann Pharmacother. 2005;39(3):452-9. https://doi.org/10.1345/aph.1E369
  40. Sullivan KM, Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am J Health Syst Pharm. 2008;65(12):1177-9. https://doi.org/10.2146/ajhp070307
  41. Achike FI, Smith J, Leonard S, Williams J, Browning F, Glisson J. Advancing safe drug use through interprofessional learning (IPL): a pilot study. J Clin Pharmacol. 2014;54(7):832-9. https://doi.org/10.1002/jcph.289
  42. Arici MA, Gelal A, Demiral Y, Tuncok Y. Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students. Indian J Pharmacol. 2015;47(4):436-9. https://doi.org/10.4103/0253-7613.161272
  43. Al-lela OQ, Elkalmi RM, Jamshed SQ. New pharmacovigilance course at the International Islamic University Malaysia-IIUM. Am J Pharm Educ. 2013;77(5):106. https://doi.org/10.5688/ajpe775106
  44. Subish P, Khanal S, Alam K, Paudel A. Introducing pharmacovigilance to postgraduate pharmacy students in Nepal. Am J Pharm Educ. 2009;73(6):114. https://doi.org/10.5688/aj7306114
  45. Pagotto C, Varallo F, Mastroianni P. Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care. 2013;29(4):410-7. https://doi.org/10.1017/S0266462313000457
  46. Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods. Drug Saf. 2011;34(9):755-62. https://doi.org/10.2165/11592800-000000000-00000
  47. Jha N, Rathore DS, Shankar PR, Bhandary S, Pandit RB, Gyawali S, et al. Effect of an educational intervention on knowledge and attitude regarding pharmacovigilance and consumer pharmacovigilance among community pharmacists in Lalitpur district, Nepal. BMC Res Notes. 2017;10(1):4. https://doi.org/10.1186/s13104-016-2343-5
  48. Yu YM, Lee E. Enhanced knowledge of spontaneous reporting with structured educational programs in Korean community pharmacists: a cross-sectional study. BMC Med Educ. 2017;17(1):95. https://doi.org/10.1186/s12909-017-0933-0
  49. Sarayani A, Naderi-Behdani F, Hadavand N, Javadi M, Farsad F, Hadjibabaie M, et al. A 3-armed randomized controlled trial of nurses' continuing education meetings on adverse drug reactions. J Contin Educ Health Prof. 2015;35(2):123-30. https://doi.org/10.1002/chp.21276
  50. Seoul National University. Undergraduate curriculum, college of medicine [Internet]. Seoul: Seoul National University; 2018 [cited 2019 Nov 19]. Available from: http://en.snu.ac.kr/curriculum.
  51. Seoul National University Course Registration System. Syllabus of human, society, and medicine [Internet]. Seoul: Seoul National University; 2019 [cited 2019 Nov 20]. Available from: http://sugang.snu.ac.kr/sugang/cc/cc103.action?openSchyy=2019&openShtmFg=U000200002&openDetaShtmFg=U000300001&sbjtCd=M1923.008100
  52. Lim YC, Ji E. Educational goals extracted from homepages of pharmacy schools in Korea. Korean J Clin Pharm. 2016;26(4):291-7.
  53. Korean Association of Pharmacy Education. Administrative and managerial pharmacy. 2nd ed. Seoul: Panmuneducation; 2018.
  54. Lee MS, Lee JM, Kim NY. Regional Drug Safety Center information [Internet]. Seoul: Korea Institute of Drug Safety and Risk Management; 2016 [cited 2019 Nov 19]. Available from: https://www.drugsafe.or.kr/iwt/ds/ko/community/EgovCenterDetail.do?seqNo=509&cnrNo=00022&pageIndex=2&searchYear=&searchCondition=qestnSj&searchKeyword=%EB%8C%80%ED%95%9C%EC%95%BD%EC%82%AC%ED%9A%8C&searchGubun=&bbsId=BBSMSTR_000000000091.
  55. Korea Institute of Drug Safety and Risk Management. Training for the next generation drug safety leader [Internet]. Anyang: Korea Institute of Drug Safety and Risk Management; 2019 [cited 2019 Nov 19]. Available from: https://www.drugsafe.or.kr/iwt/ds/ko/education/EgovEduruitDetail.do?eduInfoId=RI_00000000000000169&pageIndex=1.